Is There a Role for Genetics in the Prevention of Sudden Cardiac Death?

Journal of Cardiovascular Electrophysiology

Volumn 27, Issue 9, 2016, Pages 1124-1132

  Faragli, Alessandro ^a   Underwood, Katherine ^a   Priori, Silvia G ^a,b   Mazzanti, Andrea ^a  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

acquired cardiovascular diseases; genetic testing; inherited arrhythmia syndromes; preventive strategies; sudden cardiac death

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARRHYTHMOGENESIS; ARTICLE; CARDIAC CHANNELOPATHY; CARDIOVASCULAR RISK; FUTUROLOGY; GENETIC ASSOCIATION; GENETIC RISK; GENETICS; HUMAN; INHERITANCE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH;

EID: 84985996197     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.13028     Document Type: Article

References (80)

1. Joyner MJ, Paneth N: Seven questions for personalized medicine. JAMA 2015;314:999-1000.
2. Collins FS, Varmus H: A new initiative on precision medicine. N Engl J Med 2015;372:793-795.
3. van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C: Ten years of next-generation sequencing technology. Trends Genet 2014;30:418-426.
4. Monserrat L, Mazzanti A, Ortiz-Genga M, Barriales-Villa R, Garcia-Giustiniani D, Gimeno-Blanes JR: The interpretation of genetic tests in inherited cardiovascular diseases. Cardiogenetics 2011;1:e8.
5. Ross CA, Tabrizi SJ: Huntington's disease: From molecular pathogenesis to clinical treatment. Lancet Neurol 2011;10:83-98.
6. Caulfield T, Condit C: Science and the sources of hype. Public Health Genomics 2012;15:209-217.
7. Henneman L, Vermeulen E, van El CG, Claassen L, Timmermans DR, Cornel MC: Public attitudes towards genetic testing revisited: Comparing opinions between 2002 and 2010. Eur J Hum Genet 2013;21:793-799.
8. Kuller L, Lilienfeld A, Fisher R: An epidemiological study of sudden and unexpected deaths in adults. Medicine (Baltimore) 1967;46:341-361.
9. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van Ree JW, Daemen MJ, Houben LG, Wellens HJ: Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997;30:1500-1505.
10. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO: Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-1092.
11. Iribarren C, Crow RS, Hannan PJ, Jacobs DR Jr, Luepker RV: Validation of death certificate diagnosis of out-of-hospital sudden cardiac death. Am J Cardiol 1998;82:50-53.
12. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J: Current burden of sudden cardiac death: Multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004;44:1268-1275.
13. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S: Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014;63:1636-1643.
14. Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM, Avedissian L, Pearse LA, Potter RN, Tremaine L, Gentlesk PJ, Huffer L, Reich SS, Stevenson WG, Department of Defense Cardiovascular Death Registry G: Sudden death in young adults: An autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011;58:1254-1261.
15. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G: Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-1601.
16. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm JA, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez Madrid A, Nikolaou N, Norekval TM, Spaulding C, van Veldhuisen DJ: ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015;36:2793-867.
17. Kong MH, Fonarow GC, Peterson ED, Curtis AB, Hernandez AF, Sanders GD, Thomas KL, Hayes DL, Al-Khatib SM: Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol 2011;57:794-801.
18. Lubinski A, Bissinger A, Boersma L, Leenhardt A, Merkely B, Oto A, Proclemer A, Brugada J, Vardas PE, Wolpert C: Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries—Data from the European Heart Rhythm Association White Book. Europace 2011;13:654-662.
19. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992;85:I2-10.
20. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A: Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80:10F-19F.
21. Mazzanti A, O'Rourke S, Ng K, Miceli C, Borio G, Curcio A, Esposito F, Napolitano C, Priori SG: The usual suspects in sudden cardiac death of the young: A focus on inherited arrhythmogenic diseases. Expert Rev Cardiovasc Ther 2014;12:499-519.
22. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C, Document R, Ackerman M, Belhassen B, Estes NA 3rd, Fatkin D, Kalman J, Kaufman E, Kirchhof P, Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge SP, Campbell RM, Martin ET, Quek SC, Heart Rhythm Society, European Heart Rhythm Association, Asia Pacific Heart Rhythm Society: Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013;15:1389-1406.
23. Zipes DP, Wellens HJ: Sudden cardiac death. Circulation 1998;98:2334-2351.
24. Jouven X, Desnos M, Guerot C, Ducimetiere P: Predicting sudden death in the population: The Paris Prospective Study I. Circulation 1999;99:1978-1983.
25. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, Arbogast P, Raghunathan TE, Cobb LA: Family history as a risk factor for primary cardiac arrest. Circulation 1998;97:155-160.
26. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV: Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 2006;114:1462-1467.
27. Dekker LR, Bezzina CR, Henriques JP, Tanck MW, Koch KT, Alings MW, Arnold AE, de Boer MJ, Gorgels AP, Michels HR, Verkerk A, Verheugt FW, Zijlstra F, Wilde AA: Familial sudden death is an important risk factor for primary ventricular fibrillation: A case-control study in acute myocardial infarction patients. Circulation 2006;114:1140-1145.
28. Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, Priori SG, Roden DM, George AL Jr, Goldstein SA: A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 2000;97:10613-10618.
29. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT: Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002;297:1333-1336.
30. Albert CM, MacRae CA, Chasman DI, VanDenburgh M, Buring JE, Manson JE, Cook NR, Newton-Cheh C: Common variants in cardiac ion channel genes are associated with sudden cardiac death. Circ Arrhythm Electrophysiol 2010;3:222-229.
31. Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, Hofman A, Uitterlinden AG, Witteman JC, Stricker BH: Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 2007;116:10-16.
32. Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, Prineas RJ, Bishe B, Doan BQ, Boerwinkle E, Psaty BM, Tomaselli GF, Coresh J, Siscovick DS, Marban E, Spooner PM, Burke GL, Chakravarti A: Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 2009;119:940-951.
33. Tomas M, Napolitano C, De Giuli L, Bloise R, Subirana I, Malovini A, Bellazzi R, Arking DE, Marban E, Chakravarti A, Spooner PM, Priori SG: Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol 2010;55:2745-2752.
34. Farfel Z, Bourne HR, Iiri T: The expanding spectrum of G protein diseases. N Engl J Med 1999;340:1012-1020.
35. Wieneke H, Spencker S, Svendsen JH, Martinez JG, Strohmer B, Toivonen L, Le Marec H, Garcia J, Kaup B, Soykan O, Corrado D, Siffert W: Polymorphisms associated with ventricular tachyarrhythmias: Rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study. Europace 2010;12:424-429.
36. Wieneke H, Corrado D, Lande J, Garcia Fernandez J, Svendsen J, Le Marec H, Martinez JG, Spencker S, Strohmer B, Toivonen L, Siffert W: The role of genetics in ventricular tachyarrhythmia risk stratification: Primary results from the DISCOVERY trial. J Am Coll Cardiol 2015;65:in press.
37. Aouizerat BE, Vittinghoff E, Musone SL, Pawlikowska L, Kwok PY, Olgin JE, Tseng ZH: GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc Disord 2011;11:29.
38. Bezzina CR, Pazoki R, Bardai A, Marsman RF, de Jong JS, Blom MT, Scicluna BP, Jukema JW, Bindraban NR, Lichtner P, Pfeufer A, Bishopric NH, Roden DM, Meitinger T, Chugh SS, Myerburg RJ, Jouven X, Kaab S, Dekker LR, Tan HL, Tanck MW, Wilde AA: Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat Genet 2010;42:688-691.
39. Arking DE, Junttila MJ, Goyette P, Huertas-Vazquez A, Eijgelsheim M, Blom MT, Newton-Cheh C, Reinier K, Teodorescu C, Uy-Evanado A, Carter-Monroe N, Kaikkonen KS, Kortelainen ML, Boucher G, Lagace C, Moes A, Zhao X, Kolodgie F, Rivadeneira F, Hofman A, Witteman JC, Uitterlinden AG, Marsman RF, Pazoki R, Bardai A, Koster RW, Dehghan A, Hwang SJ, Bhatnagar P, Post W, Hilton G, Prineas RJ, Li M, Kottgen A, Ehret G, Boerwinkle E, Coresh J, Kao WH, Psaty BM, Tomaselli GF, Sotoodehnia N, Siscovick DS, Burke GL, Marban E, Spooner PM, Cupples LA, Jui J, Gunson K, Kesaniemi YA, Wilde AA, Tardif JC, O'Donnell CJ, Bezzina CR, Virmani R, Stricker BH, Tan HL, Albert CM, Chakravarti A, Rioux JD, Huikuri HV, Chugh SS: Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet 2011;7:e1002158.
40. Evans DM, Visscher PM, Wray NR: Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. Hum Mol Genet 2009;18:3525-3531.
41. Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, Sharma A, Guiducci C, Perola M, Jula A, Sinisalo J, Lokki ML, Nieminen MS, Melander O, Salomaa V, Peltonen L, Kathiresan S: A multilocus genetic risk score for coronary heart disease: Case-control and prospective cohort analyses. Lancet 2010;376:1393-1400.
42. Consortium CAD. A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015;47:1121-1130.
43. Hernesniemi JA, Lyytikainen LP, Oksala N, Seppala I, Kleber ME, Mononen N, Marz W, Mikkelsson J, Pessi T, Louhelainen AM, Martiskainen M, Nikus K, Klopp N, Waldenberger M, Illig T, Kahonen M, Laaksonen R, Karhunen PJ, Lehtimaki T: Predicting sudden cardiac death using common genetic risk variants for coronary artery disease. Eur Heart J 2015;36:1669-1675.
44. Abriel H, Zaklyazminskaya EV: Cardiac channelopathies: genetic and molecular mechanisms. Gene 2013;517:1-11.
45. Fowler SJ, Priori SG. Clinical spectrum of patients with a Brugada ECG. Curr Opin Cardiol 2009;24:74-81.
46. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, Gabbarini F, Goulene K, Insolia R, Mannarino S, Mosca F, Nespoli L, Rimini A, Rosati E, Salice P, Spazzolini C: Prevalence of the congenital long-QT syndrome. Circulation 2009;120:1761-1767.
47. Mazzanti A, Kanthan A, Monteforte N, Memmi M, Bloise R, Novelli V, Miceli C, O'Rourke S, Borio G, Zienciuk-Krajka A, Curcio A, Surducan AE, Colombo M, Napolitano C, Priori SG: Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol 2014;63:1300-1308.
48. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A: Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.
49. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011;8:1308-1339.
50. Tisdale JE, Wroblewski HA, Overholser BR, Kingery JR, Trujillo TN, Kovacs RJ: Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: A prospective, observational study in a large urban academic medical center in the US. Drug Saf 2012;35:459-470.
51. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D: Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-1874.
52. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R: Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
53. Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A: Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000;102:2849-2855.
54. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ: Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960-965.
55. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J: Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004;292:1341-1344.
56. Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin JA, Priori SG, Kamakura S: Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: Multicenter study in Japan. J Am Coll Cardiol 2004;44:117-125.
57. Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S: Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007;115:2481-2489.
58. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z: Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002;105:794-799.
59. Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S: Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009;54:2052-2062.
60. Migdalovich D, Moss AJ, Lopes CM, Costa J, Ouellet G, Barsheshet A, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Goldenberg I: Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm 2011;8:1537-1543.
61. Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, Heradien M, Geldenhuys G, Vanoli E, Bacchini S, Spazzolini C, Lundquist AL, Roden DM, George AL, Jr., Schwartz PJ: Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation 2005;112:2602-2610.
62. Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, Zaklyazminskaya EV, Swan H, Ackerman MJ, Moss AJ, Wilde AA, Horie M, Brink PA, Insolia R, De Ferrari GM, Crimi G: The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: Toward a mutation-specific risk stratification. Circulation 2007;116:2366-2375.
63. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC: Compound mutations: A common cause of severe long-QT syndrome. Circulation 2004;109:1834-1841.
64. Villain E, Denjoy I, Lupoglazoff JM, Guicheney P, Hainque B, Lucet V, Bonnet D: Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 2004;25:1405-1411.
65. Monnig G, Kobe J, Loher A, Wasmer K, Milberg P, Zellerhoff S, Pott C, Zumhagen S, Radu R, Scheld HH, Haverkamp W, Schulze-Bahr E, Eckardt L: Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: A long-term follow-up. Europace 2012;14:396-401.
66. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, Gasparini M, Wilde AA, Knops RE, Denjoy I, Toivonen L, Monnig G, Al-Fayyadh M, Jordaens L, Borggrefe M, Holmgren C, Brugada P, De Roy L, Hohnloser SH, Brink PA: Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010;122:1272-1282.
67. Horner JM, Kinoshita M, Webster TL, Haglund CM, Friedman PA, Ackerman MJ: Implantable cardioverter defibrillator therapy for congenital long QT syndrome: A single-center experience. Heart Rhythm 2010;7:1616-1622.
68. Bennett PB, Yazawa K, Makita N, George AL Jr: Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995;376:683-685.
69. Shimizu W, Antzelevitch C: Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000;35:778-786.
70. Wang HW, Zheng YQ, Yang ZF, Li CZ, Liu YM: Effect of mexiletine on long QT syndrome model. Acta Pharmacol Sin 2003;24:316-320.
71. Priori SG, Napolitano C, Cantu F, Brown AM, Schwartz PJ: Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res 1996;78:1009-1015.
72. Fabritz L, Kirchhof P, Franz MR, Nuyens D, Rossenbacker T, Ottenhof A, Haverkamp W, Breithardt G, Carmeliet E, Carmeliet P: Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. Cardiovasc Res 2003;57:1085-1093.
73. Ruan Y, Liu N, Bloise R, Napolitano C, Priori SG: Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients. Circulation 2007;116:1137-1144.
74. Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M, Novelli V, Baiardi P, Bagnardi V, Etheridge SP, Napolitano C, Priori SG: Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. J Am Coll Cardiol 2016;67:1053-1058.
75. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E: The elusive link between LQT3 and Brugada syndrome: The role of flecainide challenge. Circulation 2000;102:945-947.
76. Kubota T, Shimizu W, Kamakura S, Horie M: Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1. J Cardiovasc Electrophysiol 2000;11:1048-1054.
77. Li EC, Esterly JS, Pohl S, Scott SD, McBride BF: Drug-induced QT-interval prolongation: Considerations for clinicians. Pharmacotherapy 2010;30:684-701.
78. Denegri M, Avelino-Cruz JE, Boncompagni S, De Simone SA, Auricchio A, Villani L, Volpe P, Protasi F, Napolitano C, Priori SG: Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias. Circ Res 2012;110:663–668.
79. Denegri M, Bongianino R, Lodola F, Boncompagni S, De Giusti VC, Avelino-Cruz JE, Liu N, Persampieri S, Curcio A, Esposito F, Pietrangelo L, Marty I, Villani L, Moyaho A, Baiardi P, Auricchio A, Protasi F, Napolitano C, Priori SG: Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age. Circulation 2014;129:2673-2681.
80. Teramoto T, Kawamori R, Miyazaki S, Teramukai S, Mori Y, Okuda Y, Hiramatsu K, Group OS: Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: The OMEGA study risk factor sub-analysis. Clin Exp Hypertens 2014;36:236-243.